Anticoagulant Therapy For Acute Coronary Syndromes
نویسندگان
چکیده
منابع مشابه
Anticoagulant Therapy in Acute Coronary Syndromes with Focus on Fondaparinux ACUTE CORONARY SYNDROMES | REVIEW
In this context, bleeding is the most frequent non-ischaemic complication observed in ACS. It has a strong impact on the outcome, with a dosedependent association between bleeding and risk of death or other ischaemic events. Major bleeding was shown to be associated with a four-fold increase in the risk of death, a five-fold increase in the risk of recurrent MI and a three-fold increase in the ...
متن کاملStatin Therapy in Acute Coronary Syndromes
Randomized trials have established that statin treatment reduces coronary events in primary prevention and in patients with stable coronary artery disease. In unstable coronary artery disease, however, the pathophysiological background is distinct, and the potential benefits of statin therapy have not been evaluated until recently. Data from animal models and clinical studies indicate that stat...
متن کاملAntiplatelet therapy in acute coronary syndromes.
INTRODUCTION Coronary thrombosis is a frequent cause of death and myocardial infarction most often explained by superimposition of a platelet-rich thrombus on existing coronary artery disease. Therefore, antiplatelet drugs are essential in the treatment and secondary prevention of acute coronary syndromes (ACS) and during percutaneous coronary intervention. Several novel antiplatelet drugs are ...
متن کاملPrognostic value of C-Reactive Protein in Acute Coronary Syndromes
Introduction: Coronary artery disease (CAD) is among the most common, serious, chronic and life- threatening illnesses in the world. CAD represents a spectrum of conditions, with acute myocardial infarction at one end of it and silent ischemia at the other. There is growing evidence on importance of prognosis of C- reactive protein (CPR) in unstable angina and this protein is a maker of an adve...
متن کاملCombining antiplatelet drugs and oral anticoagulant therapy in atrial fibrillation: acute coronary syndromes and/or percutaneous coronary intervention/stenting revisited.
Combining Antiplatelet Drugs and Oral Anticoagulant Therapy in Atrial Fibrillation: Acute Coronary Syndromes and/or Percutaneous Coronary Intervention/Stenting Revisited To the Editor: We agree with Gorelick1 that there is little evidence that combination aspirin and oral anticoagulant (OAC) therapy among patients with atrial fibrillation (AF) improves stroke prevention but, instead, increases ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Interventional Cardiology Review
سال: 2018
ISSN: 1756-1477
DOI: 10.15420/icr.2017:26:1